{"disease":{"id":"clostridioides-difficile-infection-recurrence","name":"clostridioides difficile infection recurrence"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06979609","title":"Secondary Prevention of Clostridioides Difficile Using Vancomycin","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"McGill University Health Centre/Research Institute of the McGill University Health Centre","has_results":false},{"nct_id":"NCT03788434","title":"Phase 2 Study of VE303 for Prevention of Recurrent Clostridioides Difficile Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":79,"lead_sponsor_name":"Vedanta Biosciences, Inc.","has_results":true},{"nct_id":"NCT07458984","title":"FMT Capsules for rCDI","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":76,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":false},{"nct_id":"NCT07250724","title":"C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Bactolife A/S","has_results":false},{"nct_id":"NCT05304715","title":"Bezlotoxumab Yielded Outcomes by Addressing Personalized Needs in Clostridioides Difficile Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":44,"lead_sponsor_name":"Hellenic Institute for the Study of Sepsis","has_results":true},{"nct_id":"NCT05739825","title":"Changes in Recipients Gut Microbiota After Fecal Microbiota Transplantation","phase":"","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}